<DOC>
	<DOCNO>NCT00195455</DOCNO>
	<brief_summary>The purpose study evaluate vasomotor symptom ( VMS ) control continuous regimen 17 b estradiol/trimegestone combination .</brief_summary>
	<brief_title>Study Evaluating Estradiol/Trimegestone Vasomotor Symptoms ( VMS ) Post-Menopausal Women .</brief_title>
	<detailed_description />
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Generally healthy postmenopausal woman 45 55 year age inclusive , least 1 year natural occur amenorrhea , vasomotor symptom , least 4 hot flush per day Intact uterus Known suspect breast carcinoma estrogendependent neoplasm Undiagnosed abnormal genital bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Postmenopause</keyword>
</DOC>